Concordia Healthcare (CXRX) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Concordia Healthcare Announces Second Quarter 2015 Results
August 13, 2015 6:30 PM EDT-         Newly acquired Covis assets drive top line and EBITDA2 in the second quarter    -
Second Quarter 2015 Highlights
The Company completed its acquisition of substantially all of the commercial assets of privately held Covis Pharma S.Ã .r.l and Covis Injectables, S.Ã .r.l (together "Covis") for $1.2 billion. The acquired Covis portfolio consists of 12 branded products, 5 authorized generic products and a product distributed by a third party in Australia. The Company paid for the assets through a mix of term loans, bonds and equity as disclosed in prior press releases.... More


